Piroxicam EP Impurity F | CAS 76508-37-7 - Request Quote
Piroxicam EP Impurity F
| SZ CAT No: | SZ-P069007 |
| CAS No | 76508-37-7 |
| Mol.F. | C12H13NO5S |
| Mol.Wt. | 283.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Piroxicam EP Impurity F is chemically 1-Methylethyl (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate (as per EP). Piroxicam EP Impurity F is supplied with detailed characterization data compliant with regulatory guideline. Piroxicam EP Impurity F can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Piroxicam.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 76508-37-7
Purchase 76508-37-7
Order 76508-37-7
Enquire 76508-37-7
price of 76508-37-7
76508-37-7 Supplier
76508-37-7 Manufacturer
76508-37-7 Exporter
buy high quality Piroxicam EP Impurity F
Purchase Piroxicam EP Impurity F
Piroxicam EP Impurity F suppliers
Piroxicam EP Impurity F manufacturers
Piroxicam EP Impurity F price
Order Piroxicam EP Impurity F
Enquire Piroxicam EP Impurity F
Piroxicam EP Impurity F cost
Piroxicam EP Impurity F Supplier
Piroxicam EP Impurity F Distributor
Piroxicam EP Impurity F for Method Validation
Piroxicam Reference Standard
Piroxicam EP Impurity F for ANDA Filing
Piroxicam EP Impurity F for Forced Degradation Studies
Piroxicam EP Impurity F Identification Standards
Piroxicam EP Impurity F for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.